MXCT vs XRAY · rev $38.6M vs rev $3.68B
MaxCyte Inc (MXCT) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
MXCT currently screens at market cap $124.3M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the MXCT and XRAY stock pages for the full models.
Not investment advice.